Tag: Japan

ISPOR ATTENDING 2016 HTAi ANNUAL MEETING IN TOKYO THIS MAY

ANNOUNCEMENT Princeton, NJ—April 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) will be attending the Health Technology Assessment international (HTAi) 2016 Annual Meeting in Tokyo, Japan on May 10-14, 2016.

Posted in Announcements Tagged with: , , , , , ,

TREATMENT PREFERENCES FOR BLOOD THINNERS: COMPARISON BETWEEN PHYSICIANS AND PATIENTS WITH ATRIAL FIBRILLATION IN THE U.S. AND JAPAN

Hirosaki, Japan – Blood thinners (anticoagulants) are crucial in preventing strokes among patients with atrial fibrillation (AF) but are associated with increased risk of bleeding. As described in the article, “Comparing Patient and Physician Risk Tolerance for Bleeding Events Associated with

Posted in Preference-Based Assessments, Value in Health Regional Issues Tagged with: , , ,

What Does the Future of Health Technology Assessment Hold for Mainland China, Japan, South Korea, and Taiwan?

Indianapolis, IN, USA – Diabetes mellitus (DM) is associated with significant economic and humanistic burden. The condition presents a real challenge in Asia, which accounts for more than 60% of individuals with DM, globally.

Posted in Value in Health Regional Issues Tagged with: , , , , ,

Is CTC Implementation Cost-Effective for Colorectal Cancer?

Tokyo, Japan – Though the incidence and mortality of colorectal cancer can be reduced by regularly screening uptake, the current screening program, fecal occult blood test (FOBT) followed by optical colonoscopy (OC), does not work well due to low uptake rate

Posted in Value in Health Regional Issues Tagged with: , , ,

Inconsistency Among Utility Values in Japanese Studies –Are All QALYs Created Equal?

Tochigi, Japan – To conduct cost–utility analyses (CUAs) for pharmaceuticals, substantial data are required. One part of these data contains the utility values used when calculating the quality-adjusted life year (QALY). Using utility data in clinical trials in Japan was uncommon;

Posted in Value in Health Regional Issues Tagged with: , , ,